00:00Like you all know that in Brisbane there's a disease from heart attack.
00:06It's about 5 to 1 times because of diabetes symptoms.
00:11I started my postdoctoral studies.
00:13I covered my treatment with various studies.
00:17I found that in Brisbane there is a lot of work through diabetes related research.
00:27I have done diabetes mellitus and diabetes mellitus is such a disease in which our blood increases and increases in
00:43our blood and increases in our blood and increases in our blood.
00:57In this case, diabetes mellitus is a single targeted disease because diabetes is a multi-targeted disease so we need
01:05to treat it as a multi-targeted disease.
01:07So, first of all, I saw that diabetes mellitus is responsible for causing diabetes.
01:17So, first of all, we have checked out which is a function that causes diabetes.
01:22I have done a transcriptomics and analysis where we got to know which genes are responsible for the progression of
01:31diabetes.
01:32In this case, we have two genes which are responsible for the progression of diabetes.
01:36In the case of the pancreas, there is an inflammation that causes inflammation.
01:43We have no production of insulin or insulin has no effect.
01:48As we have known through the analysis of the transcripters,
01:52then we have computational approaches such as molecular blocking or virtual screening.
01:56We have known chemical structures that have known through the transcripters.
02:04We have known through the action.
02:06We have saved our time and resources.
02:10Before we have confirmed that this compound, chemical structure,
02:17this is not the action.
02:20Similarly, we have also used this approach.
02:24The already existing biological potential compounds,
02:28we have modified some modifications so that the toxicity can increase
02:31and the production of insulin can increase.
02:34We have also used this approach.
02:35Because diabetes has no target.
02:39So, our approach is our title,
02:42which I'm titled is integrated approach across the world,
02:46which has increased in the area of insulin production.
02:48It also has increased...
02:48which is also increased in the results of insulin levels.
02:52I am also терmated more than the immune system.
02:54It also has reduced the overall clinical analysis.
02:57So, in terms of our clinical analysis,
02:58In the case of the MPCST, the MP Young Scientist Congress, which was in February,
03:04we provided the work of the Sampoorn project.
03:10The researchers of this work also did a great job.
03:14In this work, the MPCST was given to the Young Scientist Award.
03:19In addition to this, MPCHT has also provided financial assistance for young scientists to provide financial assistance in which I
03:30have completed my research in the future.
03:36In the future, we will also know about different types of proteins which are responsible for diabetes.
03:46In addition to this, we will also know that these small molecules are created in the body of diabetes.
03:53If we meet a target together, we call it Integrative Multi-omics Approaches.
04:01In this approach, we can find out a novel target in which the progression of diabetes is mainly happening.
04:08In this approach, there is a requirement of high computational power.
04:14It is required by law enforcement.
04:14to do
Comments